
2. For more details on the recommended changes, please refer to the updated product information for Pandemrix: http://www.emea.europa.eu/influenza/vaccines/pandemrix/pandemrix_pi.html
3. More information on adverse reactions reported with centrally authorised pandemic vaccines is provided in the weekly pandemic influenza pharmacovigilance update report: http://www.emea.europa.eu/influenza/updates.html
4. More information on the Agency's activities in relation to the influenza pandemic can be found on the Agency's pandemic influenza website: http://www.emea.europa.eu/influenza/home.htm
5. This press release, together with other information on the work of the European Medicines Agency, can be found on the Agency's website: www.emea.europa.eu